The peripheral blood transcriptome identifies the presence and extent of disease in idiopathic pulmonary fibrosis.
Peripheral blood biomarkers are needed to identify and determine the extent of idiopathic pulmonary fibrosis (IPF). Current physiologic and radiographic prognostic indicators diagnose IPF too late in the course of disease. We hypothesize that peripheral blood biomarkers will identify disease in its...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3382229?pdf=render |
id |
doaj-5a30adfc26c242fb8de6f85065fdb1e9 |
---|---|
record_format |
Article |
spelling |
doaj-5a30adfc26c242fb8de6f85065fdb1e92020-11-25T00:23:25ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0176e3770810.1371/journal.pone.0037708The peripheral blood transcriptome identifies the presence and extent of disease in idiopathic pulmonary fibrosis.Ivana V YangLeah G LunaJennifer CotterJanet TalbertSonia M LeachRaven KiddJulia TurnerNathan KummerDolly KervitskyKevin K BrownKathy BoonMarvin I SchwarzDavid A SchwartzMark P SteelePeripheral blood biomarkers are needed to identify and determine the extent of idiopathic pulmonary fibrosis (IPF). Current physiologic and radiographic prognostic indicators diagnose IPF too late in the course of disease. We hypothesize that peripheral blood biomarkers will identify disease in its early stages, and facilitate monitoring for disease progression.Gene expression profiles of peripheral blood RNA from 130 IPF patients were collected on Agilent microarrays. Significance analysis of microarrays (SAM) with a false discovery rate (FDR) of 1% was utilized to identify genes that were differentially-expressed in samples categorized based on percent predicted D(L)CO and FVC.At 1% FDR, 1428 genes were differentially-expressed in mild IPF (D(L)CO >65%) compared to controls and 2790 transcripts were differentially- expressed in severe IPF (D(L)CO >35%) compared to controls. When categorized by percent predicted D(L)CO, SAM demonstrated 13 differentially-expressed transcripts between mild and severe IPF (< 5% FDR). These include CAMP, CEACAM6, CTSG, DEFA3 and A4, OLFM4, HLTF, PACSIN1, GABBR1, IGHM, and 3 unknown genes. Principal component analysis (PCA) was performed to determine outliers based on severity of disease, and demonstrated 1 mild case to be clinically misclassified as a severe case of IPF. No differentially-expressed transcripts were identified between mild and severe IPF when categorized by percent predicted FVC.These results demonstrate that the peripheral blood transcriptome has the potential to distinguish normal individuals from patients with IPF, as well as extent of disease when samples were classified by percent predicted D(L)CO, but not FVC.http://europepmc.org/articles/PMC3382229?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ivana V Yang Leah G Luna Jennifer Cotter Janet Talbert Sonia M Leach Raven Kidd Julia Turner Nathan Kummer Dolly Kervitsky Kevin K Brown Kathy Boon Marvin I Schwarz David A Schwartz Mark P Steele |
spellingShingle |
Ivana V Yang Leah G Luna Jennifer Cotter Janet Talbert Sonia M Leach Raven Kidd Julia Turner Nathan Kummer Dolly Kervitsky Kevin K Brown Kathy Boon Marvin I Schwarz David A Schwartz Mark P Steele The peripheral blood transcriptome identifies the presence and extent of disease in idiopathic pulmonary fibrosis. PLoS ONE |
author_facet |
Ivana V Yang Leah G Luna Jennifer Cotter Janet Talbert Sonia M Leach Raven Kidd Julia Turner Nathan Kummer Dolly Kervitsky Kevin K Brown Kathy Boon Marvin I Schwarz David A Schwartz Mark P Steele |
author_sort |
Ivana V Yang |
title |
The peripheral blood transcriptome identifies the presence and extent of disease in idiopathic pulmonary fibrosis. |
title_short |
The peripheral blood transcriptome identifies the presence and extent of disease in idiopathic pulmonary fibrosis. |
title_full |
The peripheral blood transcriptome identifies the presence and extent of disease in idiopathic pulmonary fibrosis. |
title_fullStr |
The peripheral blood transcriptome identifies the presence and extent of disease in idiopathic pulmonary fibrosis. |
title_full_unstemmed |
The peripheral blood transcriptome identifies the presence and extent of disease in idiopathic pulmonary fibrosis. |
title_sort |
peripheral blood transcriptome identifies the presence and extent of disease in idiopathic pulmonary fibrosis. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2012-01-01 |
description |
Peripheral blood biomarkers are needed to identify and determine the extent of idiopathic pulmonary fibrosis (IPF). Current physiologic and radiographic prognostic indicators diagnose IPF too late in the course of disease. We hypothesize that peripheral blood biomarkers will identify disease in its early stages, and facilitate monitoring for disease progression.Gene expression profiles of peripheral blood RNA from 130 IPF patients were collected on Agilent microarrays. Significance analysis of microarrays (SAM) with a false discovery rate (FDR) of 1% was utilized to identify genes that were differentially-expressed in samples categorized based on percent predicted D(L)CO and FVC.At 1% FDR, 1428 genes were differentially-expressed in mild IPF (D(L)CO >65%) compared to controls and 2790 transcripts were differentially- expressed in severe IPF (D(L)CO >35%) compared to controls. When categorized by percent predicted D(L)CO, SAM demonstrated 13 differentially-expressed transcripts between mild and severe IPF (< 5% FDR). These include CAMP, CEACAM6, CTSG, DEFA3 and A4, OLFM4, HLTF, PACSIN1, GABBR1, IGHM, and 3 unknown genes. Principal component analysis (PCA) was performed to determine outliers based on severity of disease, and demonstrated 1 mild case to be clinically misclassified as a severe case of IPF. No differentially-expressed transcripts were identified between mild and severe IPF when categorized by percent predicted FVC.These results demonstrate that the peripheral blood transcriptome has the potential to distinguish normal individuals from patients with IPF, as well as extent of disease when samples were classified by percent predicted D(L)CO, but not FVC. |
url |
http://europepmc.org/articles/PMC3382229?pdf=render |
work_keys_str_mv |
AT ivanavyang theperipheralbloodtranscriptomeidentifiesthepresenceandextentofdiseaseinidiopathicpulmonaryfibrosis AT leahgluna theperipheralbloodtranscriptomeidentifiesthepresenceandextentofdiseaseinidiopathicpulmonaryfibrosis AT jennifercotter theperipheralbloodtranscriptomeidentifiesthepresenceandextentofdiseaseinidiopathicpulmonaryfibrosis AT janettalbert theperipheralbloodtranscriptomeidentifiesthepresenceandextentofdiseaseinidiopathicpulmonaryfibrosis AT soniamleach theperipheralbloodtranscriptomeidentifiesthepresenceandextentofdiseaseinidiopathicpulmonaryfibrosis AT ravenkidd theperipheralbloodtranscriptomeidentifiesthepresenceandextentofdiseaseinidiopathicpulmonaryfibrosis AT juliaturner theperipheralbloodtranscriptomeidentifiesthepresenceandextentofdiseaseinidiopathicpulmonaryfibrosis AT nathankummer theperipheralbloodtranscriptomeidentifiesthepresenceandextentofdiseaseinidiopathicpulmonaryfibrosis AT dollykervitsky theperipheralbloodtranscriptomeidentifiesthepresenceandextentofdiseaseinidiopathicpulmonaryfibrosis AT kevinkbrown theperipheralbloodtranscriptomeidentifiesthepresenceandextentofdiseaseinidiopathicpulmonaryfibrosis AT kathyboon theperipheralbloodtranscriptomeidentifiesthepresenceandextentofdiseaseinidiopathicpulmonaryfibrosis AT marvinischwarz theperipheralbloodtranscriptomeidentifiesthepresenceandextentofdiseaseinidiopathicpulmonaryfibrosis AT davidaschwartz theperipheralbloodtranscriptomeidentifiesthepresenceandextentofdiseaseinidiopathicpulmonaryfibrosis AT markpsteele theperipheralbloodtranscriptomeidentifiesthepresenceandextentofdiseaseinidiopathicpulmonaryfibrosis AT ivanavyang peripheralbloodtranscriptomeidentifiesthepresenceandextentofdiseaseinidiopathicpulmonaryfibrosis AT leahgluna peripheralbloodtranscriptomeidentifiesthepresenceandextentofdiseaseinidiopathicpulmonaryfibrosis AT jennifercotter peripheralbloodtranscriptomeidentifiesthepresenceandextentofdiseaseinidiopathicpulmonaryfibrosis AT janettalbert peripheralbloodtranscriptomeidentifiesthepresenceandextentofdiseaseinidiopathicpulmonaryfibrosis AT soniamleach peripheralbloodtranscriptomeidentifiesthepresenceandextentofdiseaseinidiopathicpulmonaryfibrosis AT ravenkidd peripheralbloodtranscriptomeidentifiesthepresenceandextentofdiseaseinidiopathicpulmonaryfibrosis AT juliaturner peripheralbloodtranscriptomeidentifiesthepresenceandextentofdiseaseinidiopathicpulmonaryfibrosis AT nathankummer peripheralbloodtranscriptomeidentifiesthepresenceandextentofdiseaseinidiopathicpulmonaryfibrosis AT dollykervitsky peripheralbloodtranscriptomeidentifiesthepresenceandextentofdiseaseinidiopathicpulmonaryfibrosis AT kevinkbrown peripheralbloodtranscriptomeidentifiesthepresenceandextentofdiseaseinidiopathicpulmonaryfibrosis AT kathyboon peripheralbloodtranscriptomeidentifiesthepresenceandextentofdiseaseinidiopathicpulmonaryfibrosis AT marvinischwarz peripheralbloodtranscriptomeidentifiesthepresenceandextentofdiseaseinidiopathicpulmonaryfibrosis AT davidaschwartz peripheralbloodtranscriptomeidentifiesthepresenceandextentofdiseaseinidiopathicpulmonaryfibrosis AT markpsteele peripheralbloodtranscriptomeidentifiesthepresenceandextentofdiseaseinidiopathicpulmonaryfibrosis |
_version_ |
1725357134491680768 |